Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
International Journal of Molecular Sciences
|
June 25, 2020
Downregulation of PPARα during Experimental Left Ventricular Hypertrophy Is Critically Dependent on Nox2 NADPH Oxidase Signalling
Adam P Harvey, Emma Robinson, Kevin S Edgar, et al.
Cancer Research
|
February 15, 2019
ACE: A Workbench Using Evolutionary Genetic Algorithms for Analyzing Association in TCGA
Alan R Gilmore, Matthew Alderdice, Kienan I Savage, et al.
Nature Communications
|
June 1, 2017
Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification
Philip D Dunne, Matthew Alderdice, Paul G O'Reilly, et al.
The Journal of Pathology
|
February 8, 2018
Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies
Matthew Alderdice, Susan D Richman, Simon Gollins, et al.
NAR Genomics and Bioinformatics
|
April 30, 2021
Evolutionary genetic algorithm identifies <i>IL2RB</i> as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancer
Matthew Alderdice, Stephanie G Craig, Matthew P Humphries, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 17, 2017
Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survival
Matthew Alderdice, Philip D Dunne, Aidan J Cole, et al.
Oncotarget
|
August 29, 2015
Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility
Muhammad A Alvi, Darragh G McArt, Paul Kelly, et al.
Oncotarget
|
March 24, 2018
<i>Bcl-xL</i> as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in <i>BRAF</i>-mutant stage II and III colon cancer
Philip D Dunne, Helen G Coleman, Peter Bankhead, et al.
British Journal of Cancer
|
July 21, 2020
Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia
Stephanie G Craig, Matthew P Humphries, Matthew Alderdice, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
International Journal of Molecular Sciences
|
June 25, 2020
Downregulation of PPARα during Experimental Left Ventricular Hypertrophy Is Critically Dependent on Nox2 NADPH Oxidase Signalling
Adam P Harvey, Emma Robinson, Kevin S Edgar, et al.
Cancer Research
|
February 15, 2019
ACE: A Workbench Using Evolutionary Genetic Algorithms for Analyzing Association in TCGA
Alan R Gilmore, Matthew Alderdice, Kienan I Savage, et al.
Nature Communications
|
June 1, 2017
Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification
Philip D Dunne, Matthew Alderdice, Paul G O'Reilly, et al.
The Journal of Pathology
|
February 8, 2018
Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies
Matthew Alderdice, Susan D Richman, Simon Gollins, et al.
NAR Genomics and Bioinformatics
|
April 30, 2021
Evolutionary genetic algorithm identifies <i>IL2RB</i> as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancer
Matthew Alderdice, Stephanie G Craig, Matthew P Humphries, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 17, 2017
Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survival
Matthew Alderdice, Philip D Dunne, Aidan J Cole, et al.
Oncotarget
|
August 29, 2015
Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility
Muhammad A Alvi, Darragh G McArt, Paul Kelly, et al.
Oncotarget
|
March 24, 2018
<i>Bcl-xL</i> as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in <i>BRAF</i>-mutant stage II and III colon cancer
Philip D Dunne, Helen G Coleman, Peter Bankhead, et al.
British Journal of Cancer
|
July 21, 2020
Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia
Stephanie G Craig, Matthew P Humphries, Matthew Alderdice, et al.
Page
of 1